{"id":33955,"date":"2013-09-30T21:57:39","date_gmt":"2013-09-30T21:57:39","guid":{"rendered":"http:\/\/www.mixedracestudies.org\/wordpress\/?p=33955"},"modified":"2013-09-30T21:57:39","modified_gmt":"2013-09-30T21:57:39","slug":"i-consider-racialized-medicine-to-be-the-inappropriate-use-of-racial-categories-in-medical-practice-and-drug-development","status":"publish","type":"post","link":"https:\/\/mixedracestudies.org\/wp\/?p=33955","title":{"rendered":"I consider racialized medicine to be the inappropriate use of racial categories in medical practice and drug development."},"content":{"rendered":"<blockquote><p>I consider racialized medicine to be the inappropriate use of racial categories in medical practice and drug development. It often involves constructing practices around mistaken assumptions of some innate genetic difference among racial groups. For me, the important issue is not whether to use race in biomedicine, but how to use it\u2013and when. There are very real health disparities in the country that are based on a long history of social, economic, and legal practices that have consistently and deliberately subordinated groups of people based on their race. As a social and historical phenomenon the health impacts of race are very real and can only be addressed by taking race into account. The key is to recognize that in these contexts it is the social and historical practices of racism that have become manifest in racialized bodies as the very real biological differences of health disparities. That is, it is history and culture that has created these biological differences in the incidence of disease across racial groups\u2013not genes. \u2014<a href=\"http:\/\/law.hamline.edu\/dr-jonathan-kahn.html\" target=\"_blank\">Jonathan Kahn<\/a><\/p><\/blockquote>\n<p>\u201cAn Interview with <em>Race in a Bottle<\/em> author Jonathan Kahn,\u201d <em>Columbia University Press<\/em>, (January 16, 2013). <a href=\"http:\/\/www.cupblog.org\/?p=8710\">http:\/\/www.cupblog.org\/?p=8710<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>I consider racialized medicine to be the inappropriate use of racial categories in medical practice and drug development. It often involves constructing practices around mistaken assumptions of some innate genetic difference among racial groups. For me, the important issue is not whether to use race in biomedicine, but how to use it\u2013and when. There are [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[2548,1265],"class_list":["post-33955","post","type-post","status-publish","format-standard","hentry","category-excerpts","tag-columbia-university-press","tag-jonathan-kahn"],"_links":{"self":[{"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=\/wp\/v2\/posts\/33955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33955"}],"version-history":[{"count":0,"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=\/wp\/v2\/posts\/33955\/revisions"}],"wp:attachment":[{"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mixedracestudies.org\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}